Karah Smith, PA
Physician Assistant · Dalton, GANPI 1285622746
Payments from drug & device makers
Across 127 payments — averaging $16.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$346
- AbbVie$342
- Pfizer$274
- Novo Nordisk$229
- Abbott$120
- Amgen$100
- plus $742 from 23 others
What the payments were for
- Food & beverage$2,153100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 24 | $346 |
| AbbVie | 19 | $342 |
| Pfizer | 17 | $274 |
| Novo Nordisk | 13 | $229 |
| Abbott | 7 | $120 |
| Amgen | 5 | $100 |
| Sanofi-aventis U.S. LLC | 5 | $92 |
| Boehringer Ingelheim | 5 | $92 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $72 |
| Medtronic | 3 | $59 |
| Phathom Pharmaceuticals, Inc. | 3 | $53 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| GSK | 2 | $37 |
| AstraZeneca | 2 | $30 |
| Astellas Pharma US Inc | 1 | $25 |
| Sumitomo Pharma America, Inc. | 2 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Averitas Pharma Inc. | 1 | $19 |
| Bausch Health US, LLC | 1 | $19 |
| Corcept Therapeutics | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Irhythm Technologies, Inc. | 1 | $17 |
| Axonics, Inc. | 1 | $17 |
| Seqirus USA Inc | 1 | $16 |
| Shield Therapeutics Inc | 1 | $15 |
| Boston Scientific | 1 | $15 |
| Novartis | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
How this compares
$2,153 in reported general payments places this provider in the 80th percentile of 3,581 physician assistant providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 96 | $84,148 |
| MounjaroTirzepatide | 64 | $70,213 |
| OzempicSemaglutide | 62 | $61,741 |
| TrulicityDulaglutide | 27 | $35,577 |
| JanuviaSitagliptin Phosphate | 35 | $32,118 |
| EliquisApixaban | 43 | $31,876 |
| FarxigaDapagliflozin Propanediol | 36 | $29,728 |
| RybelsusSemaglutide | 12 | $20,500 |
| JanumetSitagliptin Phos/Metformin Hcl | 20 | $18,593 |
| Tresiba Flextouch U-200Insulin Degludec | 11 | $17,407 |
| XareltoRivaroxaban | 13 | $14,799 |
| LinzessLinaclotide | 23 | $13,654 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $11,120 |
| PremarinEstrogens, Conjugated | 22 | $5,391 |
| Incruse ElliptaUmeclidinium Bromide | 16 | $5,217 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $346 | $105,78991 claims |
| Boehringer IngelheimJardiance | $92 | $84,14896 claims |
| Novo NordiskOzempic, Rybelsus | $229 | $82,24074 claims |
| PfizerEliquis, Premarin | $274 | $37,26665 claims |
| AstraZenecaFarxiga | $30 | $29,72836 claims |
| GSKTrelegy Ellipta, Incruse Ellipta, Breo Ellipta | $37 | $20,67844 claims |
| AbbVieLinzess, Synthroid | $342 | $15,57460 claims |
| Sanofi-aventis U.S. LLCLantus | $92 | $1,50912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,581 physician assistant providers in Georgia.
Other physician assistant in Dalton
- Douglas DiruggieroCartersville$1.3M
- Jennifer CobbsAtlanta$1M
- A BrunnerStockbridge$1M
- Joseph LangshawCalhoun$887K
- Alison MoeAtlanta$410K
- Maggie SchreckAtlanta$389K
- Lisa HillMarietta$190K
- Laura BishopBrunswick$103K
- Jaime AckermanAtlanta$84K
- Richard BurrellBrunswick$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.